Biomedical Engineering Reference
In-Depth Information
delivery to neurons and glia: a comparative
study of adult mice and nonhuman primates.
Mol Ther 19(6):1058-1069
72. Bevan AK, Duque S, Foust KD et al (2011)
Systemic gene delivery in large species for tar-
geting spinal cord, brain, and peripheral tissues
for pediatric disorders. Mol Ther 19(11):
1971-1980
73. Wishart TM, Mutsaers CA, Riessland M et al
(2014) Dysregulation of ubiquitin homeostasis
and beta-catenin signaling promote spinal mus-
cular atrophy. J Clin Invest 124(4):1821-1834
74. Schreml J, Riessland M, Paterno M et al
(2012) Severe SMA mice show organ impair-
ment that cannot be rescued by therapy with
the HDACi JNJ-26481585. Eur J Hum Genet
21(6):643-652
75. Shababi M, Habibi J, Ma L et al (2012) Partial
restoration of cardio-vascular defects in a res-
cued severe model of spinal muscular atrophy.
J Mol Cell Cardiol 52(5):1074-1082
76. Araujo Ade Q, Araujo M, Swoboda KJ (2009)
Vascular perfusion abnormalities in infants
with spinal muscular atrophy. J Pediatr
155(2):292-294
77. Rudnik-Schöneborn S, Vogelgesang S,
Armbrust S et al (2010) Digital necroses and
vascular thrombosis in severe spinal muscular
atrophy. Muscle Nerve 42(1):144-147
78. Benkhelifa-Ziyyat S, Besse A, Roda M et al
(2013) Intramuscular scAAV9-SMN injection
mediates widespread gene delivery to the spi-
nal cord and decreases disease severity in SMA
mice. Mol Ther 21(2):282-290
79. Lorson MA, Spate LD, Samuel MS et al (2011)
Disruption of the Survival Motor Neuron
(SMN) gene in pigs using ssDNA. Transgenic
Res 20(6):1293-1304
80. Baughan TD, Dickson A, Osman EY et al
(2009) Delivery of bifunctional RNAs that tar-
get an intronic repressor and increase SMN
levels in an animal model of spinal muscular
atrophy. Hum Mol Genet 18(9):1600-1611
81. Coady TH, Lorson CL (2010) Trans-splicing-
mediated improvement in a severe mouse
model of spinal muscular atrophy. J Neurosci
30(1):126-130
82. Shababi M, Glascock J, Lorson CL (2011)
Combination of SMN trans-splicing and a
neurotrophic factor increases the life span and
body mass in a severe model of spinal muscular
atrophy. Hum Gene Ther 22(2):135-144
83. Shababi M, Lorson CL (2012) Optimization
of SMN trans-splicing through the analysis of
SMN introns. J Mol Neurosci 46(3):459-469
84. Baughan T, Shababi M, Coady TH et al
(2006) Stimulating full-length SMN2 expres-
sion by delivering bifunctional RNAs via a viral
vector. Mol Ther 14(1):54-62
85. Coady TH, Shababi M, Tullis GE et al (2007)
Restoration of SMN function: delivery of a
trans-splicing RNA re-directs SMN2 pre-
mRNA splicing. Mol Ther 15(8):1471-1478
86. Coady TH, Baughan TD, Shababi M et al
(2008) Development of a single vector system
that enhances trans-splicing of SMN2 tran-
scripts. PLoS One 3(10):e3468
87. Hua Y, Vickers TA, Baker BF et al (2007)
Enhancement of SMN2 exon 7 inclusion by
antisense oligonucleotides targeting the exon.
PLoS Biol 5(4):e73
88. Gottschall PE, Komaki G, Arimura A (1992)
Increased circulating interleukin-1 and inter-
leukin-6 after intracerebroventricular injection
of lipopolysaccharide. Neuroendocrinology
56(6):935-938
89. Veerendra Kumar MH, Gupta YK (2002)
Intracerebroventricular administration of col-
chicine produces cognitive impairment associ-
ated with oxidative stress in rats. Pharmacol
Biochem Behav 73(3):565-571
90. Zhang SJ, Deng YM, Zhu YL et al (2010)
Intracerebroventricular injection of leukotri-
ene B4 attenuates antigen-induced asthmatic
response via BLT1 receptor stimulating HPA-
axis in sensitized rats. Respir Res 11:39
91. Shultz SR, MacFabe DF, Ossenkopp KP et al
(2008) Intracerebroventricular injection of
propionic acid, an enteric bacterial metabolic
end-product, impairs social behavior in the rat:
implications for an animal model of autism.
Neuropharmacology 54(6):901-911
92. Shultz SR, Macfabe DF, Martin S et al (2009)
Intracerebroventricular injections of the enteric
bacterial metabolic product propionic acid impair
cognition and sensorimotor ability in the Long-
Evans rat: further development of a rodent model
of autism. Behav Brain Res 200(1):33-41
93. Rodriguez Diaz M, Abdala P, Barroso-Chinea
P et al (2001) Motor behavioural changes after
intracerebroventricular injection of
6-hydroxydopamine in the rat: an animal
model of Parkinson's disease. Behav Brain Res
122(1):79-92
94. Ally A, Hand GA, Mitchell JH (1996)
Cardiovascular responses to static exercise in
conscious cats: effects of intracerebroventricu-
lar injection of clonidine. J Physiol 491(2):
519-527
95. Neuhuber B, Barshinger AL, Paul C et al
(2008) Stem cell delivery by lumbar puncture
as a therapeutic alternative to direct injection
into injured spinal cord. J Neurosurg Spine
9(4):390-399
96. Glascock JJ, Osman EY, Coady TH et al (2011)
Delivery of therapeutic agents through intra-
cerebroventricular (ICV) and intravenous (IV)
injection in mice
.
J Vis Exp (56), pii: 2968
Search WWH ::
Custom Search